Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2015 Publisher: Wockhardt UK Ltd, Ash Road North, Wrexham, LL13 9UF
Hyalase 1500 I.U. Powder for Solution for Injection/Infusion or Hyaluronidase 1500 I.U. Powder for Solution for Injection/Infusion
| Pharmaceutical Form |
|---|
|
Powder for solution for injection/infusion. A white, sterile freeze-dried powder for solution for injection or infusion. |
Each ampoule contains 1,500 international units of Hyaluronidase.
For excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Hyaluronidase |
Hyaluronidase is an enzyme that has a temporary and reversible depolymerising effect on the polysaccharide hyaluronic acid, which is present in the intercellular matrix of connective tissue. |
| List of Excipients |
|---|
|
None. |
1ml neutral glass ampoule containing a plug of white freeze-dried powder.
Pack size: 10 ampoules.
Wockhardt UK Ltd, Ash Road North, Wrexham, LL13 9UF
UK: PL 29831/0113
Malta: MA 154/01701
5th February 1993
| Drug | Countries | |
|---|---|---|
| HYALASE | Hong Kong, Israel, Malta, New Zealand, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
